Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products.
52W Range
1stpctl
Volume
0.07×avg
Market Cap
1.28MUSD
P/E Ratio
-0.2TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Matinas BioPharma Holdings, Inc.
MTNBNew York Stock Exchange Arca·USD·Closed
Matinas BioPharma Holdings, Inc.
MTNBNew York Stock Exchange Arca·USD·Closed
$0.20
+0.00%
$0.20
+$0.00 (0.00%)
52W Range
1stpctl
Volume
0.07×avg
Mkt Cap
1.28MUSD
P/E
-0.2TTM
Div Yield
–ann
MTNB: Matinas BioPharma Holdings, Inc. Stock Analysis | finqOS
